Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.

Also Known As:

Anti-NMDA Receptor Encephalitis; Anti-NMDAR Encephalitis; Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Non-paraneoplastic Anti-NMDA Receptor Encephalitis; Non-paraneoplastic Anti-NMDAR Encephalitis; Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Paraneoplastic Anti-NMDA Receptor Encephalitis; Paraneoplastic Anti-NMDAR Encephalitis; Anti N Methyl D Aspartate Receptor Encephalitis; Anti NMDA Receptor Encephalitis; Anti NMDAR Encephalitis; Anti-N-Methyl-D-Aspartate Receptor Encephalitides; Anti-NMDA Receptor Encephalitides; Anti-NMDAR Encephalitides; Anti-NMDAR Encephalitides, Non-paraneoplastic; Anti-NMDAR Encephalitides, Paraneoplastic; Anti-NMDAR Encephalitis, Non-paraneoplastic; Anti-NMDAR Encephalitis, Paraneoplastic; Encephalitides, Anti-N-Methyl-D-Aspartate Receptor; Encephalitides, Anti-NMDA Receptor; Encephalitides, Anti-NMDAR; Encephalitides, Non-paraneoplastic Anti-NMDAR; Encephalitides, Paraneoplastic Anti-NMDAR; Encephalitis, Anti-N-Methyl-D-Aspartate Receptor; Encephalitis, Anti-NMDA Receptor; Encephalitis, Anti-NMDAR; Encephalitis, Non-paraneoplastic Anti-NMDAR; Encephalitis, Paraneoplastic Anti-NMDAR; Non paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis; Non paraneoplastic Anti NMDA Receptor Encephalitis; Non paraneoplastic Anti NMDAR Encephalitis; Non-paraneoplastic Anti-NMDAR Encephalitides; Paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis; Paraneoplastic Anti NMDA Receptor Encephalitis; Paraneoplastic Anti NMDAR Encephalitis; Paraneoplastic Anti-NMDAR Encephalitides; Receptor Encephalitides, Anti-NMDA; Receptor Encephalitis, Anti-NMDA

Neoplasms: 1324753
- Paraneoplastic Syndromes: 1065
  - Nervous System Paraneoplastic Syndromes: 125
    - Anti-N-Methyl-D-Aspartate Receptor Encephalitis: 804
- Neoplasms by Site: 4
  - Nervous System Neoplasms: 235
    - Nervous System Paraneoplastic Syndromes: 125
      - Anti-N-Methyl-D-Aspartate Receptor Encephalitis: 804
Nervous System Diseases: 14178
- Neurodegenerative Diseases: 42472
  - Nervous System Paraneoplastic Syndromes: 125
    - Anti-N-Methyl-D-Aspartate Receptor Encephalitis: 804
- Neuroinflammatory Diseases: 18166
  - Encephalitis: 8461
    - Anti-N-Methyl-D-Aspartate Receptor Encephalitis: 804
- Central Nervous System Diseases: 4213
  - Brain Diseases: 15694
    - Encephalitis: 8461
      - Anti-N-Methyl-D-Aspartate Receptor Encephalitis: 804
Immune System Diseases: 4321
- Autoimmune Diseases: 34618
  - Autoimmune Diseases of the Nervous System: 1461
    - Anti-N-Methyl-D-Aspartate Receptor Encephalitis: 804

Katharina Plenk Selected Research

Katharina Plenk Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure